Adaptive Immunity and Th Responses to Fungi

Adaptive immunity against fungi is the antigen-specific arm of host defence, in which dendritic cells instruct CD4+ T helper (Th) cells to differentiate into protective subsets that confer durable, tailored protection. For many fungi the protective programme is dominated by Th17 and Th1 responses, with the Th17/IL-17 axis being especially important for defence at mucosal surfaces.

Definition

Adaptive antifungal immunity is the antigen-specific response in which CD4+ T helper cells differentiate into effector subsets—principally Th17 and Th1—that coordinate durable protection against fungi, complemented by antibody responses.

Scope

This topic covers T-cell-mediated antifungal immunity: the priming of CD4+ T cells by antigen-presenting cells, the differentiation and functions of Th17 and Th1 subsets, the role of IL-17 in mucosal defence, and the consequences of defects in these pathways. It is a reference and educational entry on adaptive antifungal immunology, not clinical guidance.

Core questions

• How are antifungal CD4+ T-cell responses primed?
• Why is the Th17/IL-17 axis central to mucosal antifungal defence?
• What are the respective roles of Th1 and Th17 responses?
• What happens to antifungal defence when these T-cell pathways fail?

Key concepts

• CD4+ T helper cell differentiation
• Th17 cells and IL-17
• Th1 cells and interferon-gamma
• Mucosal antifungal immunity
• Antigen presentation by dendritic cells
• Immunological memory to fungi

Mechanisms

After innate recognition, dendritic cells present fungal antigens and provide cytokine signals that steer naive CD4+ T cells toward effector fates. Th17 cells, producing IL-17 and IL-22, are critical at mucosal and epithelial surfaces, where IL-17 drives the recruitment of neutrophils and the production of antimicrobial peptides that control fungi such as Candida albicans (hernandez-santos-2012). Th1 cells, producing interferon-gamma, support phagocyte activation and are important for control of several systemic mycoses. The balance and integration of these subsets, together with antigen presentation and the development of immunological memory, determine the durability of protection (netea-2015). Human studies show that disruption of the Th17/IL-17 pathway is closely tied to chronic mucocutaneous fungal disease, underscoring the non-redundant role of this axis (lionakis-2018).

Clinical relevance

The reliance of mucosal antifungal defence on the Th17/IL-17 axis explains why genetic or acquired impairment of this pathway, or of CD4+ T cells generally, is linked to recurrent or chronic mucocutaneous fungal disease. This topic describes those immunological relationships for educational understanding and is not a basis for individual diagnosis or treatment.

Evidence & guidelines

The synthesis here is based on mechanistic and narrative reviews integrating experimental immunology with human cohort observations (hernandez-santos-2012; netea-2015; lionakis-2018). It is not clinical guidance.

History

The recognition that the Th17 lineage is a dedicated arm of antifungal adaptive immunity emerged in the late 2000s and early 2010s, when IL-17-producing T cells were tied to mucosal defence against Candida. Parallel human genetics—defects in IL-17 immunity producing chronic mucocutaneous candidiasis—confirmed the non-redundant role of this axis and reframed antifungal adaptive immunity around Th17 and Th1 subsets (hernandez-santos-2012; lionakis-2018).

Key figures

• Sarah L. Gaffen
• Nydiaris Hernández-Santos
• Mihai G. Netea
• Michail S. Lionakis

Seminal works

• hernandez-santos-2012
• lionakis-2018

Frequently asked questions

Why are Th17 cells important against fungi?

Th17 cells produce IL-17, which recruits neutrophils and induces antimicrobial peptides at mucosal surfaces, making this axis central to defence against mucosal fungal infections such as candidiasis.

How do Th1 and Th17 responses differ in antifungal defence?

Th1 cells produce interferon-gamma to activate phagocytes and help control systemic fungal infection, whereas Th17 cells and IL-17 are especially important for protecting mucosal and epithelial surfaces.